Unsurprisingly, our results showed that LTBP4 silencing significantly inhibited the expression of cleaved caspase-3 and E-cadherin, but up-regulated that of Ki67 in melanoma cells, while these effects were abolished by LTBP4 overexpression, consistent with the above studies. The gene discussed is CASP3; the disease is melanoma.